Editorial: Mechanism and pharmacodynamic material basis of neurodegenerative disease therapies.
作者信息
Wu Erxi, Ke Ronghu, Qi Dan, Huang Jason H
机构信息
Department of Neurosurgery and Neuroscience Institute, Baylor Scott and White Health, Temple, TX, United States.
Department of Medical Education, Texas A&M University School of Medicine, Temple, TX, United States.
出版信息
Front Neurosci. 2023 Jul 21;17:1254881. doi: 10.3389/fnins.2023.1254881. eCollection 2023.
Abstract
摘要
相似文献
1
Editorial: Mechanism and pharmacodynamic material basis of neurodegenerative disease therapies.社论：神经退行性疾病治疗的机制及药效物质基础
Front Neurosci. 2023 Jul 21;17:1254881. doi: 10.3389/fnins.2023.1254881. eCollection 2023.
2
Natural polyphenols effects on protein aggregates in Alzheimer's and Parkinson's prion-like diseases.天然多酚对阿尔茨海默病和帕金森病朊病毒样疾病中蛋白质聚集体的影响。
Neural Regen Res. 2018 Jun;13(6):955-961. doi: 10.4103/1673-5374.233432.
3
Infections among individuals with multiple sclerosis, Alzheimer's disease and Parkinson's disease.多发性硬化症、阿尔茨海默病和帕金森病患者的感染情况。
Brain Commun. 2023 Mar 16;5(2):fcad065. doi: 10.1093/braincomms/fcad065. eCollection 2023.
4
Editorial: Translational advances in Alzheimer's, Parkinson's, and other dementia: Molecular mechanisms, biomarkers, diagnosis, and therapies, volume II.社论：阿尔茨海默病、帕金森病及其他痴呆症的转化进展：分子机制、生物标志物、诊断与治疗，第二卷
Front Aging Neurosci. 2022 Oct 10;14:1045828. doi: 10.3389/fnagi.2022.1045828. eCollection 2022.
5
Natural Products as the Potential to Improve Alzheimer's and Parkinson's Disease.天然产物在改善阿尔茨海默病和帕金森病方面的潜力。
Int J Mol Sci. 2023 May 16;24(10):8827. doi: 10.3390/ijms24108827.
6
New drug treatments show neuroprotective effects in Alzheimer's and Parkinson's diseases.新的药物治疗在阿尔茨海默病和帕金森病中显示出神经保护作用。
Neural Regen Res. 2014 Nov 1;9(21):1870-3. doi: 10.4103/1673-5374.145342.
7
New therapeutic strategy for Parkinson's and Alzheimer's disease.帕金森病和阿尔茨海默病的新治疗策略。
Curr Med Chem. 2010;17(25):2764-74. doi: 10.2174/092986710791859324.
8
Editorial: Translational Advances in Alzheimer's, Parkinson's, and Other Neurodegenerative Dementias.社论：阿尔茨海默病、帕金森病及其他神经退行性痴呆的转化医学进展
Front Aging Neurosci. 2022 Mar 17;14:858467. doi: 10.3389/fnagi.2022.858467. eCollection 2022.
9
Common signatures of differential microRNA expression in Parkinson's and Alzheimer's disease brains.帕金森病和阿尔茨海默病大脑中差异微小RNA表达的常见特征。
Brain Commun. 2022 Oct 28;4(6):fcac274. doi: 10.1093/braincomms/fcac274. eCollection 2022.
10
Novel Therapeutics for the Treatment of Alzheimer's and Parkinson's Disease.用于治疗阿尔茨海默病和帕金森病的新型疗法。
Curr Pharm Des. 2020;26(7):755-763. doi: 10.2174/1381612826666200107161051.
本文引用的文献
1
2023 Alzheimer's disease facts and figures.2023 年阿尔茨海默病事实和数据。
Alzheimers Dement. 2023 Apr;19(4):1598-1695. doi: 10.1002/alz.13016. Epub 2023 Mar 14.
2
Hallmarks of neurodegenerative diseases.神经退行性疾病的特征。
Cell. 2023 Feb 16;186(4):693-714. doi: 10.1016/j.cell.2022.12.032.
3
A multiomics approach to heterogeneity in Alzheimer's disease: focused review and roadmap.多组学方法研究阿尔茨海默病的异质性：重点综述与路线图
Brain. 2020 May 1;143(5):1315-1331. doi: 10.1093/brain/awz384.
4
Catalpol protects synaptic proteins from beta-amyloid induced neuron injury and improves cognitive functions in aged rats.梓醇可保护突触蛋白免受β-淀粉样蛋白诱导的神经元损伤，并改善老年大鼠的认知功能。
Oncotarget. 2017 May 17;8(41):69303-69315. doi: 10.18632/oncotarget.17951. eCollection 2017 Sep 19.
5
Smilagenin attenuates beta amyloid (25-35)-induced degeneration of neuronal cells via stimulating the gene expression of brain-derived neurotrophic factor.斯米立醇通过刺激脑源性神经营养因子的基因表达来减轻β淀粉样肽（25-35）诱导的神经元细胞变性。
Neuroscience. 2012 May 17;210:275-85. doi: 10.1016/j.neuroscience.2012.03.017. Epub 2012 Mar 13.
Zotero 插件